Sera Prognostics, Inc. (SERA)
2.175
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 16:00
2.175
0.00 (0.00%)
After-Hours: 16:06
Sera Prognostics Total Assets (Quarterly) : 86.74M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 86.74M |
| March 31, 2026 | 93.54M |
| December 31, 2025 | 102.55M |
| September 30, 2025 | 108.12M |
| June 30, 2025 | 111.83M |
| March 31, 2025 | 118.18M |
| December 31, 2024 | 72.75M |
| September 30, 2024 | 79.00M |
| June 30, 2024 | 84.86M |
| March 31, 2024 | 89.89M |
| December 31, 2023 | 95.44M |
| September 30, 2023 | 90.06M |
| Date | Value |
|---|---|
| June 30, 2023 | 96.68M |
| March 31, 2023 | 105.61M |
| December 31, 2022 | 116.33M |
| September 30, 2022 | 116.56M |
| June 30, 2022 | 125.06M |
| March 31, 2022 | 134.86M |
| December 31, 2021 | 147.03M |
| September 30, 2021 | 153.69M |
| June 30, 2021 | 95.07M |
| March 31, 2021 | 62.74M |
| December 31, 2020 | 14.80M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 638.90M |
| BioRestorative Therapies, Inc. | 4.640M |
| CareDx, Inc. | 532.99M |
| Natera, Inc. | 2.657B |
| Exagen, Inc. | 51.94M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.36M |
| Shareholders Equity (Quarterly) | 59.38M |
| Debt to Equity Ratio | 0.0505 |
| Current Ratio | 1.976 |
| Net Debt Paydown Yield | -0.68% |